The Gal-3/TNF- α ratio was higher in the sera of patients with TNM stages III + IV, but this difference did not reach statistical significance ( Figure 2(a) ).
← all excerpts
Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma.
1
—
—